November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Douglas Flora: UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference
Nov 14, 2024, 17:23

Douglas Flora: UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference

Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on LinkedIn:

“Join Me at the UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference!

I am excited to attend this upcoming conference, which will be held December 11-12 in Lexington, KY. This event is a fantastic opportunity to connect with healthcare professionals dedicated to advancing cancer care across the Commonwealth.

We’ll cover a wide range of critical topics, from quality standards and genetic testing to oncology financial navigation and the latest in cardio-oncology. I’ll share insights on how AI-driven decision-support systems can enhance diagnostic accuracy, personalize care, and empower oncologists in treatment planning.

Take advantage of this chance to learn, network, and gain new tools to elevate your practice!

  • Location: Central Bank Center, Lexington, KY
  • Register Here: 2024 MCCAN Cancer Care Conference Registration
  • MCCAN Members and UK Faculty/Staff attend for free; general audience admission is $100.

I look forward to seeing you there and diving into the future of cancer care together!”

Douglas Flora: UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.